News

Neurologic Syndrome in Covid-19 Patients: Understanding the Neurotropic Potential of SARS-Cov-2

Increasing evidence shows that Coronaviruses are not always confined to the respiratory tract, but may also invade the central nervous system inducing neurological diseases. There have been extensive reports that Coronaviruses cause central nervous system infection, as well as presumed para-infectious disorders.

News

The Burden of COVID-19 on Diabetic Patients

Over 3.5 million global cases of Covid-19 have been confirmed, causing global devastation and intensifying the burden of disease for those with existing comorbidities. The call for submissions of commentaries, original articles, and case reports regarding issues with COVID-19 in patients with diabetes, aims to improve the comprehension of the disease and support physicians in the care of fragile patients .

News

The “EBV Theory” for Multiple Sclerosis: Novel Therapeutic Strategies

The Epstein-Barr Virus (EBV) is present in around 95% of the world's adult population. It generally establishes a lifelong latent infection in human B cells with little or no adverse effects. However, it can have a devastating impact on human life, leading to the development of serious illnesses. The association between EBV infection and the development of MS is widely supported by a higher rate of EBV activation in MS patients.

News

Diabetic Cardiomyopathy & Mitochondrial Dysfunction: Emerging Therapeutic Options

Cardiovascular complications are the leading cause of morbidity and mortality in diabetic patients. Although Diabetes Mellitus increases the incidence of Heart Failure, significant numbers of cardiovascular complications still occur when typical risk factors are not present. Potential targeted therapies are emerging for Diabetic Cardiomyopathy.